Fallopian Tube Cancer Clinical Trials in Minneapolis, Minnesota
3 recruitingMinneapolis, Minnesota
Showing 1–3 of 3 trials
Recruiting
Phase 2
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Endometrioid Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+1 more
TORL Biotherapeutics, LLC230 enrolled66 locationsNCT06690775
Recruiting
Phase 1
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Ovarian CancerGynecologic CancerFallopian Tube Cancer+1 more
Masonic Cancer Center, University of Minnesota33 enrolled1 locationNCT06342986
Recruiting
Phase 2
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian CancerEndometrial CancerFallopian Tube Cancer+1 more
Corcept Therapeutics270 enrolled45 locationsNCT06906341